Insider trades
Edgar Engleman, Director of Bolt Biotherapeutics BOLT, has filed 0 purchases and 12 sales on the open market. The latest trade was on 23/11/30.
Edgar Engleman
Director
- Company
- Bolt Biotherapeutics BOLT
- First filing
- 23/06/14
- Trades
- 13 trades
- Buys / sales
- 0 / 12
- 12-month net buying
- No record
- Last trade
- 23/11/30
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
BOLT | Open-market sale | 23/11/29–23/11/30 | 23/12/01 | 148,884 sh4 trades | $0.87avg. | $129,330.49 | −37.2% |
BOLT | Open-market sale | 23/11/21 | 23/11/22 | 1,943 sh2 trades | $0.90avg. | $1,748.7 | −0.7% |
BOLT | Open-market sale | 23/11/16–23/11/20 | 23/11/20 | 49,173 sh6 trades | $0.93avg. | $45,675.45 | −15.4% |